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Background: Endogenous endophthalmitis secondary to Nocardia species is extremely rare but often portends a
poor visual prognosis often owing to the advanced nature of disease at presentation and delay in diagnosis.
Patients who are systemically immunosuppressed are at greatest risk and early suspicion of the role of this
organism in patients with acute panuveitis is paramount.
Findings: A 66-year-old cardiac transplant patient on oral prednisone, Myfortic, and tacrolimus developed unilateral
panuveitis with a focal white subretinal and retinal lesion. His past medical history was notable for Aspergillus
pneumonia and cytomegalovirus retinitis in the contralateral eye 12 months prior. Aqueous humor sampling for
eubacterial, eufungal, and viral PCR testing, as well as vitreous cultures for bacteria and fungi were unsuccessful in
the identification of a causative organism. Progressive enlargement of the lesion was noted despite intravitreal
foscarnet, vancomycin, ceftazidime, and voriconazole. A pars plana vitrectomy and retinal and subretinal biopsy led
to the identification of Nocardia veterana, a recently identified Nocardia species. A combination of linezolid,
meropenem, azithromycin, ceftriaxone, and intravitreal amikacin resulted in eradication of the infection.
Conclusion: This is the first reported case of N. veterana endogenous endophthalmitis in an immunosuppressed
patient. Pars plana vitrectomy with a subretinal biopsy was required to establish a diagnosis, as other testing
including aqueous PCR and vitreous cultures were negative. The poor visual outcome in our patient highlights the
importance of early consideration of Nocardia in the differential diagnosis of panuveitis with subretinal disease in
the context of immunosuppression.
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Introduction
Nocardia species are gram-positive, aerobic, filamentous
rods found in soil and vegetation, which may cause oppor-
tunistic infections in immunocompromised individuals.
Most commonly associated with localized pulmonary
infections, nocardiosis has also been reported in associ-
ation with cerebral and pulmonary invasion, and life-
threatening systemic dissemination. Recently, polymerase
chain reaction (PCR) testing has led to the identification
of a novel Nocardia species, Nocardia veterana [1]. Al-
though there are rare case reports of N. veterana infec-
tion of the lungs, abdomen, and disseminated disease* Correspondence: steven.yeh@emory.edu
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in any medium, provided the original work is p[2,3], there are no prior reports of N. veterana as a
cause of endogenous endophthalmitis. We report a case
of N. veterana endogenous endophthalmitis in an im-
munocompromised host following cardiac transplantation.
Pars plana vitrectomy and subretinal biopsy were required
to establish the diagnosis and initiate appropriate anti-
microbial therapy.
Case report
A 66-year-old male presented with decreased vision,
floaters, and mild pain in the right eye (OD) of 1-week
duration. Past medical history was significant for
orthotopic cardiac transplant 18 months prior, diabetes,
and Aspergillus pneumonia 2-months prior. The patient
had a history cytomegalovirus (CMV) retinitis in the left
eye for which he received a ganciclovir implant and
which we observed to be inactive for 1 year. His medica-
tions included prednisone 20 mg daily, mycophenolicOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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Summit, NJ, USA) 180 mg twice daily, tacrolimus (Prograf,
Astellas Pharma US, Inc., Northbrook, USA) 1.5 mg daily,
and posaconazole 20 mg daily. Ophthalmic drops included
brimonidine 0.15% three times daily, and prednisolone
acetate 1% (Pred Forte, Allergan, Inc., Irvine, USA) once
daily in the left eye.
Ophthalmic examination showed visual acuities of
counting fingers at 2 feet in the right eye and 20/20 in
the left eye. His pupils were briskly reactive without an
afferent pupillary defect. The intraocular pressures were
12 mmHg OD and 13 mmHg OS. Slit lamp examination
of the right eye revealed trace conjunctival injection with
2 to 3+ anterior chamber and vitreous cell. Slit lamp
examination of the left eye was unremarkable. Fundus
examination of the right eye showed 2+ vitreous haze
with a poorly visualized white retinal and subretinal le-
sion in the superior periphery with overlying punctate
hemorrhages (Figure 1). Fundus examination of the left
eye showed a chorioretinal scar superotemporally corre-
sponding to the area of prior CMV retinitis. There was
no vitreous haze or active retinitis, and a ganciclovir im-
plant was well-positioned inferotemporally.A
C
Figure 1 Photograph and B-scan ultrasound of the left eye. (A) Fun
haze obscuring the posterior pole. (B) At the 12:30 meridian, there is a d
overlying punctate retinal hemorrhage. (C) B-scan ultrasound confirming
height and 7.1 × 7.2 mm in basal diameter.The differential diagnosis included CMV retinitis,
endophthalmitis from fungus, bacteria, mycobacteria,
or atypical mycobacteria, toxoplasmosis, EBV-related
lymphoproliferative disorder, and intraocular lymphoma.
Given the patient's history of CMV retinitis in the fellow
eye, the patient underwent anterior chamber paracentesis
and intravitreal foscarnet injection (2.4 mg/0.1 mL). Aque-
ous PCR testing for Varicella zoster virus (VZV), CMV,
Herpes simplex virus (HSV), and Toxoplasma gondii DNA
were negative. Bacterial and fungal blood cultures showed
no growth, and T. gondii IgG and IgM were negative.
Valganciclovir therapy was deferred because of baseline
neutropenia. Prednisolone acetate 1% every 2 h and atro-
pine sulfate 1% were initiated with some improvement of
the patient's photophobia.
One week later, the patient's visual acuity decreased
to hand motions. The patient continued to have 2+
anterior chamber cell and 3+ vitreous haze, and the
area of the retinal and subretinal whitening had ex-
panded (Figure 2). Intravitreal injections of vancomycin
(1 mg/0.1 cc), ceftazidime (2.25 mg/0.1 cc), and
voriconazole (400 mcg/0.1 cc) were administered. Vit-
reous cultures were sent for gram and fungal stains, asB
dus photograph of the left eye at presentation showing 2+ vitreous
ome-shaped region of retinal and subretinal whitening with
the presence of a superior subretinal mass measuring 1.7 mm in
A B
Figure 2 Repeat B-scan ultrasound and pathologic evaluation. (A) Repeat B-scan ultrasound 1 week following initial presentation confirmed
enlargement of the lesion measuring 2.6 mm in height and 9.7 × 10.3 mm in basal diameter. (B) Pathologic evaluation of the subretinal aspirate and
vitreous specimen showed a cluster of gram-positive filamentous organisms consistent with Nocardia species (Brown and Brenn method, ×100).
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sent for eubacterial PCR, eufungal PCR, and Aspergillus
PCR, given the patient's recent history of Aspergillus
pneumonia. All tests were negative.
The patient subsequently underwent diagnostic pars
plana vitrectomy and a retinal biopsy, given the en-
largement of the subretinal mass and unknown eti-
ology. During the vitrectomy, a few retinal holes were
observed in the region of the subretinal mass. These
holes were used to aspirate the subretinal material.
The vitreous specimen, subretinal aspirate, and retinal
biopsy were sent for pathologic evaluation. Air-fluid ex-
change, endolaser, and 14% C3F8 gas tamponade were
performed, and intravitreal ceftazidime (2.25 mg/0.1 cc)
and vancomycin (1 mg/0.1 cc) were administered. Speci-
mens were sent for flow cytometry; PCR testing for VZV,
HSV, CMV, and toxoplasmosis; and for gram stain, AFB
stain, aerobic, anaerobic, and fungal cultures. Pathologic
evaluation of the subretinal aspirate and vitreous speci-
men showed gram-positive filamentous bacteria consist-
ent with Nocardia or Actinomyces. Cultures continued to
show no growth, and the samples were sent to the mo-
lecular diagnostics laboratory of the Centers for Disease
Control (Atlanta, Georgia, USA) for 16S ribosomal
RNA analysis. The vitreous fluid culture eventually
grew N. veterana identified using PCR. The specimen
was sensitive to amikacin, clarithromycin, linezolid, and
trimethoprim/sulfamethoxazole with intermediate sensi-
tivity to ceftriaxone and imipenem.
The patient was admitted to the hospital for intraven-
ous (IV) meropenem (2 g loading, followed by 1 g IV every
12 h adjusted for creatinine clearance of 29 mL/min) and
linezolid (600 mg IV every 12 h). Aztihromycin 500 mg
daily was substituted for linezolid after 6 weeks be-
cause of thrombocytopenia. In addition, meropenem
was discontinued after 6 weeks and switched to ceftriaxone
2 grams IV every 12 h for more reliable central nervous
system penetration. Both azithromycin and ceftriaxonewere continued with a plan to continue the medications
for 12 months. Magnetic resonance imaging showed no
evidence of brain involvement. On ophthalmic exam, the
retinal biopsy site was flat, and the subretinal infiltrates
appeared stable. In conjunction with systemic antibiotics,
intravitreal amikacin (400 mcg/0.1 cc) was administered
weekly for 3 weeks with continued improvement of the ret-
inal and subretinal lesion.
Two months following vitrectomy, the patient's visual
acuity declined to light perception only, and a retinal de-
tachment was observed on B-scan ultrasound. The patient
underwent vitrectomy, membrane peel, and silicone oil
tamponade with successful reattachment of the retina. His
visual acuity improved to counting fingers at 9 months
follow-up with an attached retina and no evidence of re-
current infection.
Discussion
Ocular infection by Nocardia is rare and most cases
are acquired exogenously from trauma or following
ocular surgery. Nocardia endogenous endophthalmitis
is exceedingly rare, with fewer than forty cases
reported since 1967 [4]. The majority of these cases
have been reported in immunocompromised patients
as a result of hematogenous dissemination, most often
from a primary pulmonary focus. Associated causes of
immunosuppression in these individuals have included
untreated HIV infection, organ transplantation, sys-
temic lupus erythematosus, cancer, and steroid use
[3]. Our case was unique in that N. veterana has not
been previously reported to cause endophthalmitis.
N. veterana was first isolated in 2001 from a veteran
soldier in Australia with bilateral upper lobe pneumonia,
giving rise to its veterana nomenclature and bears 16S
rDNA similarities to N. vaccinii [1]. Notably, several
cases of N. veterana lung infection have also been asso-
ciated with concurrent aspergillus, CMV, or Pneumocys-
tis jiroveci infection [3,5-7], likely as a result of severe
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presented with a history of CMV retinitis and Asper-
gillus pneumonia, which preceded the development of
N. veterana endophthalmitis. A decrease in the im-
munosuppressive medications and concomitant anti-
microbial therapy eventually led to eradication of the
intraocular infection. Although the patient's visual
acuity was poor at final follow-up, the retina remained
attached and the globe was salvaged in this case.
Prior studies have estimated that 0.6% to 1% of patients
with systemic nocardiosis will develop endogenous
endophthalmitis [4]. Only two isolated infections have been
reported in the absence of systemic infection. The diagno-
sis is often difficult to establish because of its slow growth
on culture media and lack of definitive clinical findings.
Moreover, diagnostic and therapeutic guidelines for ocular
infection have not been established and are frequently as-
sociated with poor visual and anatomic outcomes [1].
In a review of 38 patients with endogenous Nocardia
endophthalmitis reported over a 40-year period, the
majority of patients had underlying systemic illness
resulting in immunosuppression; specifically, 46% of
those affected were transplant recipients, 24% had auto-
immune disease, and 19% had hematologic malignancy.
In those cases of endophthalmitis associated with trans-
plantation, nocardial infection occurred within the first
year of transplantation in 11 of 17 cases. Corticosteroids
were the most common immunosuppressive therapy used
by 73% alone or in combination with other immuno-
suppressive medications [4]. Our patient's nocardial
endophthalmitis occurred 18 months after transplantation
while on combination immunosuppression with prednis-
one 20 mg/day, mycophenolic acid, and tacrolimus.
The most typical presentation of nocardial endoph-
thalmitis is decreased vision and eye pain. The most
common examination findings are the presence of an-
terior chamber inflammation (37%), vitreous inflamma-
tion (37%), and a single chorioretinal lesion (69%).
Diagnosis in most cases required diagnostic vitrectomy
for ocular specimens (50%) with an average time to
diagnosis of 3.5 weeks [4].
Retinal detachment has been reported in up to 40% of
patients with nocardial endophthalmitis [4]. Our patient
experienced a retinal detachment related to proliferative
vitreoretinopathy, which ultimately required repeat vitrec-
tomy, membrane peeling, and long-term silicone oil tam-
ponade. An improvement in the nocardial infection was
observed at the time of the retinal detachment repair, al-
though long-term antibiotics are being continued to ensure
disease control. The strain of N. veterana in our patient
was susceptible to multiple antibiotics, and prior reports
suggest that the majority of such patients may be treated
successfully with trimethoprim and sulfamethoxazole.
However, 13% of nocardial endophthalmitis patients werenot effectively treated using this trimethoprim/sulfameth-
oxazole alone [4]. For this reason, intravitreal amikacin has
been reported as an alternative treatment strategy and was
used in combination with systemic antimicrobials to
achieve control of the nocardial infection.
The systemic and visual prognosis for patients with
Nocardia endogenous endophthalmitis is extremely
guarded to poor in many cases, often because of delayed
diagnosis and other sequelae including the high frequency
of secondary complications, such as retinal detachment,
that may lead to visual loss. Specifically, in one series, 32%
of patients died, only 31% of patients recovered visual acu-
ity of 20/40 to 20/200, and 34% of patients were 20/200 or
poorer; moreover, 31% of patients were 20/40 or better at
final follow-up [4].
In summary, this is the first report of endogenous
endophthalmitis from N. veterana. Although our patient's
infection was eventually controlled with antimicrobial
treatment, his visual acuity was ultimately limited by
the retinal detachment, likely related to the severe,
advanced nature of the infection and development of
proliferative vitreoretinopathy. Nocardia, while a rare cause
of endophthalmitis, should be considered along with other
opportunistic infections in patients with severe immuno-
suppression presenting with endophthalmitis.
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